IRCCS Eugenio Medea

Quick facts

Phase 2 pipeline

• Etravirine Tablets · Infectious Disease
  Non-nucleoside reverse transcriptase inhibitor
• methyphenidate · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• IRCCS Eugenio Medea portfolio CI brief
• IRCCS Eugenio Medea pipeline updates RSS